selected publications

• article

  • Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE).  Immunology Letters.  77:175-180. 2001-01-01
  • Multidrug resistance-I (MDR-I) in rheumatic autoimmune disorders: Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcomes [Phénotype MDR-I de multirésistance aux traitements de fond dans les maladies rhumatismales auto-immunes: Première partie : une activité accrue de la P-glycoprotéine lymphocytaire pourrait influencer l'évolution de la polyarthrite rhumatdïde].  Revue du Rhumatisme (Edition Francaise).  67:37-47. 2000-01-01
  • Multidrug resistance-l (MDR-I) in rheumatic autoimmune disorders Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome.  Joint Bone Spine.  67:30-39. 2000-01-01
  • Profile of cytokine mRNA expression in spontaneous and UV-induced skin lesions from actinic prurigo patients 1997-01-01

• conference paper

  • Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.  Journal of Autoimmunity. 395-402. 1998-01-01